A novel neutrophil chemotactic cytokine : identification and functional characterization in malaria
一种新型中性粒细胞趋化细胞因子:疟疾中的鉴定和功能表征
基本信息
- 批准号:10670229
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Blood cell lysate from Plasmodium yoelii infected mice (7 days post-infection) showed an intense neutrophil chemotactic activity in dose-dependent fashion. Time course study revealed that the neutrophil chemotactic activity of the red cell lysate increased prior to the increase the number of infected erythrocytes. Sequence analysis of NH_2-terminal amino acid of the purified NCF from red blood cell lysate showed that the NCF is a kind of interferon-induced protein (IP18). Mapping study indicates that the epitope for neutrophil chemotactic activity exists on the central part of the molecule. Using a polyclonal antibody to IP18, time course study was performed for detecting the change of the amount of IP18 on red blood cells during the P.yoelii infection. Although slight amount of IP18 was detectable on RBC from normal mouse, the amount of IP18 was remarkably increased and peaked at day 6 after P.yoelii infection. The amount of IP18 and its mRNA was also increased in splenocytes. When IP18 was added in the culture system of P.falciparum in the presence of various concentrations of neutrophils in vitro, the parasite growth was inhibited in dose dependent fashion of neutrophils. When ubiquitin was added instead of IP18, no inhibition of the parasite growth was observed so far as examined. These results indicate that IP18 likely acts as an important molecule for the host defense system against malaria infection.
约氏疟原虫感染小鼠(感染后7天)的血细胞裂解物显示出强烈的中性粒细胞趋化活性,呈剂量依赖性。时间进程研究显示,红细胞裂解物的中性粒细胞趋化活性在感染红细胞数量增加之前增加。从红细胞裂解液中纯化的NCF的氨基端氨基酸序列分析表明,NCF是一种干扰素诱导蛋白(IP 18)。定位研究表明,中性粒细胞趋化活性的表位存在于分子的中心部分。用抗IP 18的多克隆抗体,对约氏疟原虫感染过程中红细胞上IP 18含量的变化进行了时程研究。约氏疟原虫感染后,正常小鼠红细胞中可检测到少量的IP 18,但其含量明显增加,并在感染后第6天达到高峰。脾细胞中IP18及其mRNA的量也增加。在体外培养的恶性疟原虫中,加入不同浓度的中性粒细胞,IP 18对恶性疟原虫生长的抑制作用与中性粒细胞的浓度有关。当加入泛蛋白代替IP 18时,到目前为止没有观察到对寄生虫生长的抑制。这些结果表明,IP18可能作为一个重要的分子宿主防御系统对疟疾感染。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Owhashi M,Harada M,Suguri S,Ohmae H,Ishii A: "The role of saliva of Anopheles stephensi in inflammatory response : Identification of a high molecular weight neutrophil chemotactic factor"Parasitology Research. (in press). (2001)
Owhashi M、Harada M、Suguri S、Ohmae H、Ishii A:“史氏按蚊唾液在炎症反应中的作用:高分子量中性粒细胞趋化因子的鉴定”寄生虫学研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Owhashi M,Arita H,Hayai N: "Identification of a novel eosinophil chemotactic cytokine (ECF-L) as a chitinase family protein"Journal of Biological Chemistry. 275. 1279-1286 (2000)
Owhashi M、Arita H、Hayai N:“作为几丁质酶家族蛋白的新型嗜酸性粒细胞趋化细胞因子 (ECF-L) 的鉴定”生物化学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Owhashi M., Arita H., and Niwa A.: "Production of eosinophil chemotactic factor by CD8^+ T cells in Toxocara canis-infected mice."Parasitology Research. 84. 136-138 (1998)
Owhashi M.、Arita H. 和 Niwa A.:“犬弓蛔虫感染小鼠中 CD8^ T 细胞产生嗜酸性粒细胞趋化因子。”寄生虫学研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Owhashi M,Harada M,Sogai S,Ohmae H,Ishii A: "The role of saliva of Anopheles stephensi in inflammatory response : Identification of a high molecular weight neutrophil Chemotactic factor"Parasitology Research. (in press). (2001)
Owhashi M、Harada M、Sogai S、Ohmae H、Ishii A:“史氏按蚊唾液在炎症反应中的作用:高分子量中性粒细胞趋化因子的鉴定”寄生虫学研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OHASHI Makoto其他文献
OHASHI Makoto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OHASHI Makoto', 18)}}的其他基金
The role of eisonphil chemotactic cytokine in parasitic infections
eisonphil趋化细胞因子在寄生虫感染中的作用
- 批准号:
14570214 - 财政年份:2002
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Development of platform for non-invasive, rapid, and simple analysis of cytokine secretion from single cells
开发非侵入、快速、简单分析单细胞细胞因子分泌的平台
- 批准号:
23H01824 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic approach to confer an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine in effector T cells
赋予效应T细胞中促肿瘤细胞因子IL-6抗肿瘤作用的治疗方法
- 批准号:
23K06723 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Diversity of haematopoietic cytokine receptor activation exploring with marine probes
用海洋探针探索造血细胞因子受体激活的多样性
- 批准号:
23K14019 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A
FOXA1 通过 ARID1A 调节前列腺癌中的细胞因子信号传导和免疫景观
- 批准号:
10681898 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Cytokine Regulation of Secondary Neural Progenitors
次级神经祖细胞的细胞因子调节
- 批准号:
10752901 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
A point-of-care salivary cytokine test for early detection of oral cancer
用于早期发现口腔癌的即时唾液细胞因子检测
- 批准号:
10760626 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Development of Coccidioides Cytokine Release Assay
球孢子菌细胞因子释放测定的发展
- 批准号:
10760131 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Generating a novel conditional knockout mouse for a super-enhancer that controls cytokine responsiveness
生成一种新型条件敲除小鼠,用于控制细胞因子反应的超级增强子
- 批准号:
10740932 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Cytokine receptor common beta chain alterations in mediastinal lymphomas
纵隔淋巴瘤细胞因子受体常见β链改变
- 批准号:
489197 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Operating Grants